Peritonitis is a well-known cause of mortality in peritoneal dialysis (PD) patients. We carried out a retrospective study to disclose the clinical spectrum and risk profile of peritonitis-related mortality. We analyzed 693 episodes of infectious peritonitis suffered by 565 patients (follow-up 1149 patient-years). Death was the final outcome in 41 cases (5.9% of episodes), peritonitis being directly implicated in 15.2% of the global mortality and 68.5% of the infectious mortality observed. In 41.5% of patients with peritonitis-related mortality, the immediate cause of death was a cardiovascular event. Highest mortality rates corresponded to fungal (27.5%), enteric (19.3%), and Staphylococcus aureus (15.2%) peritonitis. Multivariate analysis disclosed thatthe baseline risk of peritonitis-related mortality was significantly higher in female [relative risk (RR) 2.13, 95% confidence interval (CI) 1.24-4.09, p = 0.02], older (RR 1.10/year, CI 1.06-1.14, p < 0.0005), and malnourished patients (RR 2.51, CI 1.21-5.23, p = 0.01) with high serum C-reactive protein (s-CRP) levels (RR 4.04, CI 1.45-11.32, p = 0.008) and a low glomerular filtration rate (RR 0.75 per mL/minute, CI 0.64 -0.87, p < 0.0005). Analysis of risk after a single episode of peritonitis and/or subanalysis restricted to peritonitis caused by more aggressive micro-organisms disclosed that overall comorbidity [odds ratio (OR) 1.21, CI 1.05-1.71, p = 0.005], depression (OR 2.35, CI 1.14-4.84, p = 0.02), and time on PD at the time of the event (OR 1.02/month, CI 1.00-1.03, p = 0.02) were other predictors of mortality. In summary, the etiologic agent is a definite marker of peritonitis-related mortality but gender, age, residual renal function, inflammation (s-CRP), malnutrition, and depression are other significant correlates of this outcome. Most of these risk factors are common to cardiovascular and peritonitis-related mortality, which may explain the high incidence of cardiovascular event as the immediate cause of death in patients with peritonitis-related mortality.

This article has been cited by other articles:

				W. Fang, J. Qian, A. Lin, F. Rowaie, Z. Ni, Q. Yao, J. M. Bargman, and D. G. Oreopoulos Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre Nephrol. Dial. Transplant., December 1, 2008; 23(12): 4021 - 4028. [Abstract] [Full Text] [PDF]

				A. Vychytil, C. Remon, C. Michel, P. Williams, A. Rodriguez-Carmona, B. Marron, E. Vonesh, S. van der Heyden, J. C. D. Filho, and on behalf of the Extraneal Peritonitis Study Group Icodextrin does not impact infectious and culture-negative peritonitis rates in peritoneal dialysis patients: a 2-year multicentre, comparative, prospective cohort study Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3711 - 3719. [Abstract] [Full Text] [PDF]

				K. Baboolal, P. McEwan, S. Sondhi, P. Spiewanowski, J. Wechowski, and K. Wilson The cost of renal dialysis in a UK setting--a multicentre study Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1982 - 1989. [Abstract] [Full Text] [PDF]

				S. H. Han, S. C. Lee, S. V. Ahn, J. E. Lee, D. K. Kim, T. H. Lee, S. J. Moon, B. S. Kim, S.-W. Kang, K. H. Choi, et al. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2653 - 2658. [Abstract] [Full Text] [PDF]

				B. A. Warady, R. Feneberg, E. Verrina, J. T. Flynn, D. E. Muller-Wiefel, N. Besbas, A. Zurowska, N. Aksu, M. Fischbach, E. Sojo, et al. Peritonitis in Children Who Receive Long-Term Peritoneal Dialysis: A Prospective Evaluation of Therapeutic Guidelines J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2172 - 2179. [Abstract] [Full Text] [PDF]

				A. Shukla, Z. Abreu, and J. M. Bargman Streptococcal PD peritonitis--a 10-year review of one centre's experience Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3545 - 3549. [Abstract] [Full Text] [PDF]

Copyright © 2005 by Multimed Inc.